Really? Since when does the bloated do nothing bureaucracy care how other people's money is spent? So the MHRA will choose to throw out new emerging treatments, and stick to chemorad for the next decade or so. I agree. All Gov't tied to the Central Banks are almost insolvent. Debts are viewed as meeting cash reserve deposits, which is pure delusion. They can start by cutting bogus climate or war programs, and theft through contrived energy inflation. I'm not convinced it's going to be at the expense of turning away DCVAX on the cusp of flashworks coming on line.
Other companies do PR acceptance of approved trial design. PIP is pretty big news as it’s a prerequisite to MHRA approval for DCVax in adults. Down playing its importance goes to show you how little you may know? Pediatric trials are also under increased scrutiny for obvious reasons. The fact that the design was approved and endpoints and trial design are the same as the adult Phase 3 is a glaring admission that everything is on track in the UK. Spin it how you like however, nobody with any experience in this field believes you
Market Data 
Markets 
AI
